Tekla Life Sciences Investors vs Taiwan Semiconductor Manufacturing
A head-to-head of Tekla Life Sciences Investors (HQL) and Taiwan Semiconductor Manufacturing (TSM) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | HQL | TSM |
|---|---|---|
| Market Cap | $553.12M | $2.03T |
| P/E (TTM) | 3.07 | 33.08 |
| Forward P/E | 0.00 | 27.03 |
| P/S | 285.35 | 0.50 |
| P/B | 1.02 | 10.89 |
| EV/EBITDA | 0.00 | 24.68 |
| Dividend Yield | 10.14% | 0.37% |
| Profit Margin | 505.41% | 47.01% |
| Gross Margin | 100.00% | 59.89% |
| Operating Margin | 99.08% | 50.82% |
| Revenue Growth (YoY) | +463.30% | +36.53% |
| FCF Yield | — | 54.16% |
| Debt / Equity | — | 17.87 |
| Current Ratio | 1.74 | 2.49 |
Share:
Compare Tekla Life Sciences Investors with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.